Functional knockdown of VCAM-1 at the posttranslational level with ER retained antibodies

Journal of Immunological Methods

Volumn 341, Issue 1-2, 2009, Pages 30-40

  Strebe, N ^a   Guse, A ^a   Schungel M ^a   Schirrmann, T ^a   Hafner, M ^b   Jostock, T ^a   Hust, M ^a   Muller W ^c   Dubel S ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adhesion molecules; Intrabody; Knockdown; Recombinant antibody; scFv; VCAM 1

Indexed keywords

HYBRID PROTEIN; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE YFP FUSION PROTEIN; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; DOWN-REGULATION; ENDOPLASMIC RETICULUM; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MICE; RATS; RECOMBINANT PROTEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 59249102344     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.10.012     Document Type: Article

References (33)

1. Alvarez R.D., Barnes M.N., Gomez-Navarro J., Wang M., Strong T.V., Arafat W., Arani R.B., Johnson M.R., Roberts B.L., Siegal G.P., and Curiel D.T. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Clin. Cancer Res. 6 (2000) 3081
2. Böldicke T. Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER. J. Cell. Mol. Med. 11 (2007) 54
3. Böldicke T., Weber H., Mueller P.P., Barleon B., and Bernal M. Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR). J. Immunol. Methods 300 (2005) 146
4. Bolte S., and Cordelières F.P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224 (2006) 213
5. Cao T., and Heng B.C. Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications. Ann. Clin. Lab. Sci. 35 (2005) 227
6. Chen S.Y., Khouri Y., Bagley J., and Marasco W.A. Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 5932
7. Cybulsky M.I., Fries J.W., Williams A.J., Sultan P., Eddy R., Byers M., Shows T., Gimbrone M.A., and Collins T. Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 7859
8. Dedrick R.L., Bodary S., and Garovoy M.R. Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection. Expert Opin. Biol. Ther. 3 (2003) 85
9. Dübel S., Breitling F., Fuchs P., Zewe M., Gotter S., Welschof M., Moldenhauer G., and Little M. Isolation of IgG antibody Fv-DNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers. J. Immunol. Methods 175 (1994) 89
10. Engelhardt B., Laschinger M., Schulz M., Samulowitz U., Vestweber D., and Hoch G. The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J. Clin. Invest. 102 (1998) 2096
11. Gearing A.J., Hemingway I., Pigott R., Hughes J., Rees A.J., and Cashman S.J. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann. N. Y. Acad. Sci. 667 (1992) 324
12. Heng B.C., and Cao T. Making cell-permeable recombinant telomerase (trans-telomerase) through fusion of its catalytic subunit (hTERT) with protein transduction domains (PTD): a possible strategy to overcome replicative senescence during ex vivo culture of primary explanted cells. Med. Hypotheses 65 (2005) 199
13. Hession C., Moy P., Tizard R., Chisholm P., Williams C., Wysk M., Burkly L., Miyake K., Kincade P., and Lobb R. Cloning of murine and rat vascular cell adhesion molecule-1. Biochem. Biophys. Res. Commun. 183 (1992) 163
14. Hust M., and Dübel S. Mating antibody phage display with proteomics. Trends Biotechnol. 22 (2004) 8
15. Hust M., Toleikis L., and Dübel S. Antibody phage display. Handbook of Therapeutic Antibodies (2007), Wiley-VCH, Weinheim
16. Kontermann R.E. Intrabodies as therapeutic agents. Methods 34 (2004) 163
17. Konthur Z., Hust M., and Dübel S. Perspectives for systematic in vitro antibody generation. Gene 364 (2005) 19
18. Liu Z., Song D., Kramer A., Martin A.C., Dandekar T., Schneider-Mergener J., Bautz E.K., and Dübel S. Fine mapping of the antigen-antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster. J. Mol. Recognit. 12 (1999) 103
19. Munro S., and Pelham H.R. A C-terminal signal prevents secretion of luminal ER proteins. Cell 48 (1987) 899
20. Nagai T., Ibata K., Park E.S., Kubota M., Mikoshiba K., and Miyawaki A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20 (2002) 87
21. Nizak C., Monier S., del Nery E., Moutel S., Goud B., and Perez F. Recombinant antibodies to the small GTPase Rab6 as conformation sensors. Science 300 (2003) 984
22. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., and Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59 (1989) 1203
23. + T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat. Hum. Gene Ther. 9 (1998) 487
24. Rondon I.J., and Marasco W.A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu. Rev. Microbiol. 51 (1997) 257
25. Schmiedl A., Breitling F., and Dübel S. Expression of a bispecific dsFv-dsFv′ antibody fragment in Escherichia coli. Protein Eng. 13 (2000) 725
26. Schofield D.J., Pope A.R., Clementel V., Buckell J., Chapple S.D., Clarke K.F., Conquer J.S., Crofts A.M., Crowther S.R.E., Dyson M.R., Flack G., Griffin G.J., Hooks Y., Howat W.J., Kolb-Kokocinski A., et al. Application of phage display to high throughput antibody generation and characterization. Genome Biol. 8 (2007) R254
27. Sharar S.R., Winn R.K., and Harlan J.M. The adhesion cascade and anti-adhesion therapy: an overview. Springer Semin. Immunopathology 16 (1995) 359
28. Shimizu Y., Newman W., Tanaka Y., and Shaw S. Lymphocyte interactions with endothelial cells. Immunol. Today 13 (1992) 106
29. Taussig M.J., Stoevesandt O., Borrebaeck C.A.K., Bradbury A.R., Cahill D., Cambillau C., de Daruvar A., Dübel S., Eichler J., Frank R., Gibson T.J., Gloriam D., Gold L., Herberg F.W., Hermjakob H., et al. ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat. Methods 4 (2007) 13
30. Toleikis L., Broders O., and Dübel S. Cloning single-chain antibody fragments (scFv) from hybridoma cells. Methods Mol. Med. 94 (2004) 447
31. Visintin M., Meli G.A., Cannistraci I., and Cattaneo A. Intracellular antibodies for proteomics. J. Immunol. Methods 290 (2004) 135
32. Wu T. The role of vascular cell adhesion molecule-1 in tumor immune evasion. Cancer Res. 67 (2007) 6003
33. Zwartz G., Chigaev A., Foutz T., Larson R.S., Posner R., and Sklar L.A. Relationship between molecular and cellular dissociation rates for VLA-4/VCAM-1 interaction in the absence of shear stress. Biophys. J. 86 (2004) 1243